N-acylthiourea and N-acylurea inhibitors of the Hedgehog protein signalling pathway
First Claim
Patent Images
1. A method for manufacturing a drug, said method comprising mixing at least one pharmaceutically acceptable excipient and at least one compound with the following formula (I):
2 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to the use of acylthiourea or acylurea derivatives for the treatment of pathologies involving a tissue dysfunction associated with a deregulation of the Hedgehog protein signalling pathway, and also to novel acylthiourea or acylurea derivatives as such, to their use as a medicinal product, and to pharmaceutical compositions containing them.
-
Citations
19 Claims
- 1. A method for manufacturing a drug, said method comprising mixing at least one pharmaceutically acceptable excipient and at least one compound with the following formula (I):
- 2. A method for manufacturing a drug, said method comprising mixing at least one pharmaceutically acceptable excipient and at least one compound with the following formula (I):
- 8. Compounds with the following formula (I′
- 12. A method for treating tumors characterized by a hyperactivation of Hedgehog protein signaling pathway or neuro-degenerative type pathologies characterized by a hyperactivation of Hedgehog protein signaling pathway, comprising a step of administering at least one compound of formula (I):
-
13. A method for treating tumors characterized by a hyperactivation of Hedgehog protein signaling pathway or neuro-degenerative type pathologies characterized by a hyperactivation of Hedgehog protein signaling pathway, comprising a step of administering at least one compound of formula (I):
Specification